This suggests that claudin-18 can be a sensitive and specific marker for adenocarcinoma of the stomach and pancreatic bile duct (62), and claudin-18.2 is a valuable early marker of pancreatic bile duct tumors (60). The gene discussed is CLDN18; the disease is gastric adenocarcinoma.